These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 32797228)

  • 21. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
    J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
    Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
    Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia.
    Masyeni S; Santoso MS; Widyaningsih PD; Asmara DW; Nainu F; Harapan H; Sasmono RT
    Int J Infect Dis; 2021 Jan; 102():152-154. PubMed ID: 33115680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
    Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
    J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course.
    Higgins V; Fabros A; Wang XY; Bhandari M; Daghfal DJ; Kulasingam V
    Clin Biochem; 2021 Apr; 90():1-7. PubMed ID: 33476578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications.
    Dalakas MC; Bitzogli K; Alexopoulos H
    Front Immunol; 2021; 12():627285. PubMed ID: 33679770
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
    Semmler G; Traugott MT; Graninger M; Hoepler W; Seitz T; Kelani H; Karolyi M; Pawelka E; Aragón de La Cruz S; Puchhammer-Stöckl E; Aberle SW; Stiasny K; Zoufaly A; Aberle JH; Weseslindtner L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33602698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
    Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
    Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Validity of Serum Antibodies to SARS-CoV-2 : A Case-Control Study.
    Caturegli G; Materi J; Howard BM; Caturegli P
    Ann Intern Med; 2020 Oct; 173(8):614-622. PubMed ID: 32628534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of IgM, IgA, and IgG isotype antibodies Directed against SARS-CoV-2 spike glycoprotein and ORF8 in the course of COVID-19.
    Meinberger D; Koch M; Roth A; Hermes G; Stemler J; Cornely OA; Streichert T; Klatt AR
    Sci Rep; 2021 Apr; 11(1):8920. PubMed ID: 33903660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactivity of SARS-CoV-2 with other pathogens, especially dengue virus: A historical perspective.
    Dutta D; Ghosh A; Dutta C; Sukla S; Biswas S
    J Med Virol; 2023 Feb; 95(2):e28557. PubMed ID: 36755367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositivity to Detect COVID-19.
    Suhandynata RT; Hoffman MA; Kelner MJ; McLawhon RW; Reed SL; Fitzgerald RL
    J Appl Lab Med; 2020 Sep; 5(5):908-920. PubMed ID: 32428207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False Positivity of Anti-SARS-CoV-2 Antibodies in Patients with Acute Tropical Diseases in Thailand.
    Luvira V; Leaungwutiwong P; Thippornchai N; Thawornkuno C; Chatchen S; Chancharoenthana W; Tandhavanant S; Muangnoicharoen S; Piyaphanee W; Chantratita N
    Trop Med Infect Dis; 2022 Jul; 7(7):. PubMed ID: 35878144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies.
    Charlton CL; Kanji JN; Johal K; Bailey A; Plitt SS; MacDonald C; Kunst A; Buss E; Burnes LE; Fonseca K; Berenger BM; Schnabl K; Hu J; Stokes W; Zelyas N; Tipples G
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32665420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva.
    Pisanic N; Randad PR; Kruczynski K; Manabe YC; Thomas DL; Pekosz A; Klein SL; Betenbaugh MJ; Clarke WA; Laeyendecker O; Caturegli PP; Larman HB; Detrick B; Fairley JK; Sherman AC; Rouphael N; Edupuganti S; Granger DA; Granger SW; Collins MH; Heaney CD
    J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33067270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China.
    Tang H; Tian JB; Dong JW; Tang XT; Yan ZY; Zhao YY; Xiong F; Sun X; Song CX; Xiang CG; Tu C; Lei CT; Liu J; Su H; Huang J; Qiu Y; Miao XP; Zhang C
    Am J Kidney Dis; 2020 Oct; 76(4):490-499.e1. PubMed ID: 32628990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.